Efficacy and safety of liraglutide, a once-daily human glucagon-like peptide-1 receptor agonist, in African-American people with Type 2 diabetes: a meta-analysis of sub-population data from seven phase III trials

详细信息    查看全文

• 作者：M. E. Shomali ; D. D. Ø ; rsted and A. J. Cannon
• 刊名：Diabetic Medicine
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：34
• 期：2
• 页码：197-203
• 全文大小：280K
• ISSN：1464-5491

文摘

To evaluate the efficacy and safety of the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide in African-American people with Type 2 diabetes.